Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe

Por um escritor misterioso

Last updated 19 setembro 2024

Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe

Frontiers Clinically encountered growth phenotypes of tuberculosis-causing bacilli and their in vitro study: A review

Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases in: The American Journal of Tropical Medicine and Hygiene Volume 107 Issue 2 (2022)

Frontiers Novel CRISPR-based detection of Leishmania species

Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis - The Lancet

Diagnostics, Free Full-Text

Diagnostic performance of four lateral flow immunoassays for COVID-19 antibodies in Peruvian population

Tuberculosis conundrum - current and future scenarios: A proposed comprehensive approach combining laboratory, imaging, and computing advances

Abstracts 2022 North American Meeting for the Society of Medical Decision Making, October 23-26, 2022, 2023

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis - Zifodya, JS - 2021

Making cough count in tuberculosis care

Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe

Frontiers A Multiplex and Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Sensitive and Rapid Detection of Novel SARS-CoV-2

Recomendado para você